GoodRx Holdings, Inc. (GDRX)
NASDAQ: GDRX · Real-Time Price · USD
4.120
-0.170 (-3.96%)
At close: Apr 4, 2025, 4:00 PM
4.121
+0.001 (0.03%)
After-hours: Apr 4, 2025, 7:56 PM EDT
GoodRx Holdings Revenue
In the year 2024, GoodRx Holdings had annual revenue of $792.32M with 5.61% growth. GoodRx Holdings had revenue of $198.58M in the quarter ending December 31, 2024, with 0.99% growth.
Revenue (ttm)
$792.32M
Revenue Growth
+5.61%
P/S Ratio
2.01
Revenue / Employee
$1,073,610
Employees
738
Market Cap
1.58B
Revenue Chart
Revenue History
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 400.28B |
Johnson & Johnson | 88.82B |
Merck & Co. | 64.17B |
AbbVie | 56.33B |
AstraZeneca | 54.07B |
Novartis AG | 51.72B |
Eli Lilly and Company | 45.04B |
Thermo Fisher Scientific | 42.88B |
GDRX News
- 2 days ago - GoodRx Launches eCommerce Offering for Retail Pharmacies - PYMNTS
- 2 days ago - GoodRx Introduces New E-commerce Experience for Retail Pharmacies - Business Wire
- 12 days ago - GoodRx: Great Value For Patient Investors (Upgrade) - Seeking Alpha
- 19 days ago - GoodRx Appoints Aaron Crittenden as President of Rx Marketplace and Scott Pope, PharmD, as Chief Pharmacy Officer and Head of Clinical Engagement - Business Wire
- 26 days ago - GoodRx Report Reveals Striking Gender Divide in Prescription Medication Spending - Business Wire
- 5 weeks ago - GoodRx Reports Mixed Q4: Pharma Strength Amid Subscription Decline, Sluggish Prescription Sales - Benzinga
- 5 weeks ago - GoodRx Holdings, Inc. (GDRX) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 5 weeks ago - GoodRx Reports Fourth Quarter and Full Year 2024 Results - Business Wire